|LETTER TO THE EDITOR
|Year : 2022 | Volume
| Issue : 2 | Page : 153
Role of Vitamin D in COVID-19: Correspondence
Pathum Sookaromdee1, Viroj Wiwanitkit2
1 Private Academic Consultant, Bangkok, Thailand
2 Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India
|Date of Submission||26-Nov-2021|
|Date of Decision||10-Jan-2022|
|Date of Acceptance||22-Mar-2022|
|Date of Web Publication||10-May-2022|
Dr. Pathum Sookaromdee
Private Academic Consultant, 11 Bangkok 112 Bangkok 103320
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Sookaromdee P, Wiwanitkit V. Role of Vitamin D in COVID-19: Correspondence. Indian J Pharmacol 2022;54:153
We would like to share ideas on “Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link.” Singh et al. concluded that “Using Vitamin D as prophylaxis and/or chemotherapeutic treatment … of Vitamin D affecting many people worldwide.” We agree that Vitamin D might play a role in the management of COVID-19. Trials might be useful. Considering trial, some important concerns are hereby discussed. First, it should assess the impact of genetic polymorphism. Vitamin D-binding protein polymorphism might be associated with outcome of Vitamin D supplementation in the COVID-19 treatment. Additionally, if a trial will be performed, a background Vitamin D data of subjects should be assessed.
The effect of Vitamin D in COVID-19 might also be associated with some other modifiers. Sunlight exposure and estrogen interaction should be discussed. Estradiol is also proposed for its usefulness in managing COVID-19. There might be an interesting co-advantage of both Vitamin D and estradiol in the management of COVID-19.
Financial support and sponsorship
Conflicts of interest
The authors ask for waiving for any charge for this correspondence.
| » References|| |
Singh S, Singh CM, Ranjan A, Kumar S, Singh DK. Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link. Indian J Pharmacol 2021;53:394-402.
] [Full text]
Speeckaert MM, Delanghe JR. The potential significance of vitamin D binding protein polymorphism in COVID-19. Int J Infect Dis 2021;109:90.
Youn JY, Zhang Y, Wu Y, Cannesson M, Cai H. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells. Redox Biol 2021;46:102099.